Physician profile
Tom Porter
NPI 1013903095
$2,768.34
in general payments reported to CMS, 2019-2025
15 companies · $498 in 2025
The $498 reported for 2025 was less than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $137 · 2020: $270 · 2021: $435 · 2022: $432 · 2023: $424 · 2024: $573 · 2025: $498.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,495.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,494.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,096.24 | 2019-2025 | Infinion 16, General - Pain Management, Wavewriter Alpha Prime 16 |
| Abbott Laboratories | $254.50 | 2021-2023 | Proclaim |
| Surgentec | $248.60 | 2020 | |
| Curonix LLC | $239.71 | 2024-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Medtronic, INC. | $224.22 | 2023-2024 | Intellis Adaptivestim |
| Stimwave Technologies Incorporated | $159.79 | 2019-2021 | |
| Vertos Medical, INC. | $151.40 | 2022-2023 | Mild Device Kit |
| Nevro Corp. | $130.43 | 2023-2024 | Senza |
| Spinal Simplicity, LLC | $66.49 | 2022-2024 | Ha Minuteman G3-R |
| Grt US Holding, INC. | $56.00 | 2022 | |
| Relievant Medsystems, INC. | $39.92 | 2022-2023 | Intracept |
| Horizon Therapeutics Plc | $38.29 | 2021 | |
| Averitas Pharma INC. | $25.56 | 2024 | Qutenza |
| Medtronic USA, INC. | $21.17 | 2020 | |
| Mdd US Operations, LLC | $16.02 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tom Porter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.